CoChat

Rising prevalence of Plasmodium falciparum Artemisinin partial resistance mutations in Ethiopia

Open access

Published version of a preprint

The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index; none of the 69 sources its claims cite is checked for support yet.

Abstract

Ethiopia aims to eliminate local malaria transmission by 2030, but rising malaria cases, due to different factors, present a challenge. Understanding the prevalence and distribution of artemisinin partial resistance (ART-R) and other markers related to partner drugs as well as parasite connectivity in Ethiopia can greatly inform malaria control. We analyzed 1199 clinical Plasmodium falciparum infections from 12 sentinel sites across five regions in Ethiopia, collected between 2019 and 2023. Using two molecular inversion probe (MIP) panels targeting key drug resistance genes and genome-wide SNPs, we assessed the prevalence of resistance-associated mutations, complexity of infection (COI), and parasite relatedness through identity-by-descent (IBD) and principal component analysis (PCA). The most prevalent k13 R622I mutation appears in 15.7% of samples, with marked regional variation. Three validated ART-R mutations (P441L, P574L, A675V) are detected in Ethiopia for the first time, as far as we are aware, with A675V found exclusively in a Gambella clinic serving refugees from Sudan and South Sudan. Additionally, polymorphisms associated with resistance to partner drugs, including those in crt, mdr1, dhps, and dhfr genes, are nearly fixed. Most samples (87.2%) consist of monogenomic infections (COI = 1), and mutant parasites show high local genetic relatedness at the health facility level, suggesting clonal transmission. PCA reveals regional clustering, particularly in Gambella, highlighting the influence of local drug pressure, regional transmission dynamics, and importation as drivers of the observed drug resistance patterns. The increasing prevalence of k13 R622I and the emergence of additional ART-R mutations underscore the urgent need for enhanced ACT efficacy monitoring. Early detection of partner drug resistance and ACT failure will be essential to address malaria resurgence and support Ethiopia’s elimination goals. Ethiopia is aiming to eliminate the spread of malaria within the country by 2030. However, recent increases in malaria cases driven by several factors are making this goal more difficult to achieve. This study investigated whether malaria parasites in Ethiopia are becoming resistant to anti-malarial drugs. We analyzed blood samples collected between 2019 and 2023 from people infected with malaria at 12 health facilities across 5 regions. We focused on genetic changes in the parasites that are known to reduce the effectiveness of key malaria treatments, including artemisinin. We found that a previously reported genetic changes in the parasite, known as k13 R622I, is now widespread in Ethiopia but varies by location. We also identified three additional genetic changes linked to artemisinin resistance seen, as far as we are aware, for the first time in Ethiopia. The study shows that some drug-resistant parasites are spreading, particularly in certain areas. Our findings can be used to improve monitoring and strategies to eliminate malaria in Ethiopia. Brhane, Fola et al. survey prevalence of Plasmodium falciparum Artemisinin Partial Resistance Mutations in Ethiopia using large-scale genomic surveillance. They report the widespread presence of the K13 R622I mutation and emergence of validated resistance variants, emphasizing that continued molecular monitoring is needed to guide malaria control.

Overview

CoChat Summary

TL;DR

Genomic surveillance of 1,199 *Plasmodium falciparum* infections from 12 Ethiopian sentinel sites (2019–2023) found rising k13 R622I and the first detections in Ethiopia of P441L, P574L, and A675V, alongside near-fixed partner-drug resistance markers. The authors conclude that enhanced ACT efficacy monitoring is urgently needed to support Ethiopia’s malaria elimination goals.

Key findings

  • k13 R622I was the most prevalent artemisinin partial resistance marker at 15.7% (95% CI 13.2–18.2%), with marked regional variation (0–58.8% by health facility); the highest regional prevalence was in Amhara at 46.9% (95% CI 40.7–53.2%), and up to 53.7% was found in Andansa Health Centre in 2022.
  • Three additional WHO-validated k13 mutations were detected in Ethiopia for the first time, as far as the authors are aware: A675V in 6 samples from Gambella, P441L in 4 samples (3 Southern Region, 1 Oromia Region), and P574L in 5 samples all from Batu Health Center in Oromia; A675V was found only in a Gambella clinic serving refugees from Sudan and South Sudan.
  • Partner-drug resistance polymorphisms were nearly fixed: the mdr1 NFD haplotype occurred in 94.8% (95% CI 92.8–96.2%); dhfr S108N in 98.9%, N51I in 98.5%, C59R in 65%, and the dhfr IRN triple mutant in 61.6%; all isolates had dhps 437G, 83.1% had K540E, and the IRNGE quintuple mutation occurred in 58.6%; crt 76T occurred in 82.4%.
  • Most infections were monogenomic (87.2% with COI = 1 in the abstract; 745 samples in Results), and k13 R622I mutant parasites showed higher identity-by-descent sharing than wild-type parasites (mean IBD 0.21 vs 0.14; p = 0.0008), with local clustering suggesting clonal transmission; PCA showed regional clustering, particularly in Gambella.

Methods

  • Cross-sectional sampling was conducted at 12 Ethiopian Public Health Institute sentinel sites across five regions (Amhara, Gambella, Oromia, SNNP, Somali) from 2019 to 2023; 1,199 microscopy-positive *P. falciparum* dried blood spot samples were analyzed, excluding patients under 1 year of age or with severe malaria.
  • DNA was sequenced using two molecular inversion probe panels: one targeting key drug resistance genes (k13, mdr1, crt, dhfr, dhps) and a newly designed panel of 305 MIPs targeting common SNPs; after filtering, 855 samples and 508 high-quality biallelic SNPs were retained for population genetic analyses.
  • Analyses included drug resistance prevalence estimation, complexity of infection with THE REAL McCOIL, PCA, SNP π, pairwise FST, identity-by-descent analysis with MIPAnalyser, and linear mixed-effects models and ANOVA to assess IBD-sharing differences.

Limitations

  • The paper states that it cannot determine whether mutations emerged locally or were imported; it was cross-sectional without patient follow-up for delayed clearance or recrudescence; data reflect 2019–2023; 12 sentinel sites do not represent all malaria epidemiology in Ethiopia; and travel location/duration data were insufficient to test importation.
  • The paper also states that lack of publicly available whole-genome sequencing data with k13 A675V from East Africa and the absence of microsatellite data in this study limit origin analyses.
  • Evident from the text: after filtering, population analyses used 855 of 1,199 samples, drug resistance prevalence denominators varied by locus because genotyping success differed by locus, and sequencing coverage was better in samples with higher parasitemia.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s43856-025-01008-0

Cites

80 of 80 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Study sites and sequenced samples. a Study sites and b distribution of samples sequenced (n = 1199) per health facility and region. Colors indicate individual health facilities.
Fig. 1 Study sites and sequenced samples. a Study sites and b distribution of samples sequenced (n = 1199) per health facility and region. Colors indicate individual health facilities.CC BY-NC-ND · PubMed Central
Fig. 2 WHO-validated k13 mutation prevalences and relatedness of 622I mutant vs wildtype parasites. a Spatial distribution of WHO-validated k13 mutations by health facility (pie charts). Colors indicate which mutation, and pie chart size is proportional to sample size per study site. b Pairwise IBD sharing within 622I mutant (n = 130) vs within wildtype (n = 725). The plot shows the probability that any two isolates are identical by descent, where the x-axis indicates IBD values and the y-axis indicates the frequency of isolates sharing IBD. c Network analysis showing highly related parasite pairs (IBD ≥ 0.99) for a total of 393 samples. Each node identifies a unique isolate, and an edge is drawn between two isolates if they meet the IBD threshold. Isolates that do not have an IBD pairwise connection above a threshold are not shown. Color codes correspond to k13 R622I mutants (pink) and wild parasites (blue-green). d Pairwise IBD sharing within k13 R622I mutant versus wild parasites, showing significant differences (***P = 0.0004, two-tailed, Mann-Whitney U-test). Boxes indicate the interquartile range, the line indicates the median, the whiskers show the 95% confidence intervals, and the dots show outlier values. WHO, World Health Organization; k13, kelch13 gene; IBD, identity by descent.
Fig. 2 WHO-validated k13 mutation prevalences and relatedness of 622I mutant vs wildtype parasites. a Spatial distribution of WHO-validated k13 mutations by health facility (pie charts). Colors indicate which mutation, and pie chart size is proportional to sample size per study site. b Pairwise IBD sharing within 622I mutant (n = 130) vs within wildtype (n = 725). The plot shows the probability that any two isolates are identical by descent, where the x-axis indicates IBD values and the y-axis indicates the frequency of isolates sharing IBD. c Network analysis showing highly related parasite pairs (IBD ≥ 0.99) for a total of 393 samples. Each node identifies a unique isolate, and an edge is drawn between two isolates if they meet the IBD threshold. Isolates that do not have an IBD pairwise connection above a threshold are not shown. Color codes correspond to k13 R622I mutants (pink) and wild parasites (blue-green). d Pairwise IBD sharing within k13 R622I mutant versus wild parasites, showing significant differences (***P = 0.0004, two-tailed, Mann-Whitney U-test). Boxes indicate the interquartile range, the line indicates the median, the whiskers show the 95% confidence intervals, and the dots show outlier values. WHO, World Health Organization; k13, kelch13 gene; IBD, identity by descent.CC BY-NC-ND · PubMed Central
Fig. 3 Co-occurrence of ART-R and mdr1 mutations in Ethiopia. a Co-occurrence of K13 622I and MDR1 N86 (wild), 184F (mutant) and D1246 (wild). b Co-occurrence of K13 675 V and MDR1 N86 (wild), 184F (mutant) and D1246 (wild). Only samples (n = 747) with calls across all four loci are shown. For polygenomic infections, the dominant haplotype (≥51% allele frequency) is shown. ART-R artemisinin resistance, k13, kelch13 gene, mdr1 multidrug resistance protein 1.
Fig. 3 Co-occurrence of ART-R and mdr1 mutations in Ethiopia. a Co-occurrence of K13 622I and MDR1 N86 (wild), 184F (mutant) and D1246 (wild). b Co-occurrence of K13 675 V and MDR1 N86 (wild), 184F (mutant) and D1246 (wild). Only samples (n = 747) with calls across all four loci are shown. For polygenomic infections, the dominant haplotype (≥51% allele frequency) is shown. ART-R artemisinin resistance, k13, kelch13 gene, mdr1 multidrug resistance protein 1.CC BY-NC-ND · PubMed Central
Fig. 4 Complexity of infection, genetic diversity, and population structure of P. falciparum in Ethiopia. a Complexity of infections for P. falciparum at the regional level. Colors indicate regions, and black dots inside violin plots indicate median COI. b PCA plot of P. falciparum isolates (n = 855) at the regional level. Colors indicate the geography of sample origins, and shapes indicate k13 R622I mutation status. Each diamond or dot indicates individual parasites. The percentage of variance explained by each PCA is presented in each plot. c Nucleotide diversity (π) across different populations based on SNP minor allele frequency (MAF). Parasites from Gambella exhibit the highest SNP π values, indicating greater genetic diversity compared to other populations. Error bars represent the standard error of the mean nucleotide diversity for each population. d Pairwise differentiation of parasite populations across five regions: Amhara, Gambella, Oromia, SNNP, and Somali. The color intensity indicates the degree of differentiation, with darker shades representing higher differentiation. COI complexity of infection, PCA principal component analysis, k13 kelch13 gene, SNP single-nucleotide polymorphism, MAF minor allele frequency, π nucleotide diversity, SNNP Southern Nations, Nationalities, and Peoples’ Region.
Fig. 4 Complexity of infection, genetic diversity, and population structure of P. falciparum in Ethiopia. a Complexity of infections for P. falciparum at the regional level. Colors indicate regions, and black dots inside violin plots indicate median COI. b PCA plot of P. falciparum isolates (n = 855) at the regional level. Colors indicate the geography of sample origins, and shapes indicate k13 R622I mutation status. Each diamond or dot indicates individual parasites. The percentage of variance explained by each PCA is presented in each plot. c Nucleotide diversity (π) across different populations based on SNP minor allele frequency (MAF). Parasites from Gambella exhibit the highest SNP π values, indicating greater genetic diversity compared to other populations. Error bars represent the standard error of the mean nucleotide diversity for each population. d Pairwise differentiation of parasite populations across five regions: Amhara, Gambella, Oromia, SNNP, and Somali. The color intensity indicates the degree of differentiation, with darker shades representing higher differentiation. COI complexity of infection, PCA principal component analysis, k13 kelch13 gene, SNP single-nucleotide polymorphism, MAF minor allele frequency, π nucleotide diversity, SNNP Southern Nations, Nationalities, and Peoples’ Region.CC BY-NC-ND · PubMed Central
Fig. 5 P. falciparum parasite relatedness and connectivity across Ethiopia. a Pairwise IBD sharing across 12 health facilities. The plot shows the probability that any two isolates are identical by descent, where the x-axis indicates IBD values and the y-axis indicates the frequency (%) of isolates sharing IBD. The inset highlights highly related parasite pairs with a heavy tail in the distribution, and some highly related pairs of samples having IBD ≥ 0.90. b Pairwise IBD sharing within a health facility. Boxes indicate the interquartile range, the line indicates the median, the whiskers show the 95% confidence intervals, and dots show outlier values. c Relatedness network of highly related parasite pairs (IBD ≥ 0.90) at study site. Each dot indicates a sample and colors correspond to health facilities across five regions in Ethiopia. Each node identifies a unique isolate, and an edge is drawn between two isolates if they share their genome above IBD ≥ 0.90. Only Isolates (n = 467) that share IBD ≥ 0.90 of their genomes with any other isolates are shown. d Spatial distribution of highly related parasite pairs with IBD ≥ 0.90. Color of circles or connecting lines represents the level of IBD sharing within and between sites, respectively. The within-site shading is based upon the most related pair of parasites at the site. IBD, identity by descent; P. falciparum, Plasmodium falciparum.
Fig. 5 P. falciparum parasite relatedness and connectivity across Ethiopia. a Pairwise IBD sharing across 12 health facilities. The plot shows the probability that any two isolates are identical by descent, where the x-axis indicates IBD values and the y-axis indicates the frequency (%) of isolates sharing IBD. The inset highlights highly related parasite pairs with a heavy tail in the distribution, and some highly related pairs of samples having IBD ≥ 0.90. b Pairwise IBD sharing within a health facility. Boxes indicate the interquartile range, the line indicates the median, the whiskers show the 95% confidence intervals, and dots show outlier values. c Relatedness network of highly related parasite pairs (IBD ≥ 0.90) at study site. Each dot indicates a sample and colors correspond to health facilities across five regions in Ethiopia. Each node identifies a unique isolate, and an edge is drawn between two isolates if they share their genome above IBD ≥ 0.90. Only Isolates (n = 467) that share IBD ≥ 0.90 of their genomes with any other isolates are shown. d Spatial distribution of highly related parasite pairs with IBD ≥ 0.90. Color of circles or connecting lines represents the level of IBD sharing within and between sites, respectively. The within-site shading is based upon the most related pair of parasites at the site. IBD, identity by descent; P. falciparum, Plasmodium falciparum.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 34 Not checked · 118 Own results and interpretations

82 more claims

Create a free account to see all 152 claims and to verify the 69 references still open.

See all claims — free account
  • It may state two separate claims as one. 44
  • The quote only partly states this claim. 2
  • Probably not a substantial claim. 33

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Show all 80 references

Research works printed but not linked: 1

  1. Brhane, B. G. Rising prevalence of Plasmodium falciparum Artemisinin partial resistance mutations in Ethiopia. NCBI Sequence Read Archive. https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1170993 (2025).

Cited by

See all 29

Metadata

Authors
Brhane, B. G., Fola, A. A., Nigussie, H., Leonetti, A., Kassa, M., Hailgiorgis, H., Wuletaw, Y., Abera, A., Mohammed, H., Sime, H., G/Tsadik, A., Assefa, G., Solomon, H., Tasew, G., Tollera, G., Hailu, M., Juliano, J. J., Assefa, A., Parr, J. B., & Bailey, J. A.
Affiliations
  • Ethiopian Public Health Institute (ET)
  • Brown University (US)
  • Addis Ababa University (ET)
  • Government of Ethiopia (ET)
  • University of North Carolina at Chapel Hill (US)
Corresponding author
  • Brhane, Bokretsion G.
  • Bailey, Jeffrey A.
Venue
Communications Medicine
Published
2025-07-18
Volume
5
Issue
1
Pages
297-297
ISSN
2730-664X (ISSN-L)
OpenAlex
W4412521261
Cited by
29
References
77
Citations by year
2026: 20 · 2025: 9
FWCI
16.76
Type
journal article
Language
en
Open access
Licence
Locations
  • Communications Medicine (publishedVersion, cc-by-nc-nd)
  • medRxiv (submittedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Centers for Disease Control and Prevention
  • National Institute of Allergy and Infectious Diseases (R01AI139520, R01AI177791, K24AI134990)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
  • Life Sciences › Immunology and Microbiology › Parasitology › Bird parasitology and diseases
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Keywords
Plasmodium falciparum, partner drug resistance, chloroquine resistance, sulfonamide resistance, complexity of infection, clonal transmission, malaria resurgence, malaria elimination, Ethiopia, antimicrobial resistance surveillance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-21, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-21 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Rising prevalence of Plasmodium falciparum Artemisinin partial resistance mutations in Ethiopia. https://app.cochat.ai/papers/10.1038/s43856-025-01008-0
The paper
Brhane, B. G., Fola, A. A., Nigussie, H., Leonetti, A., Kassa, M., Hailgiorgis, H., Wuletaw, Y., Abera, A., Mohammed, H., Sime, H., G/Tsadik, A., Assefa, G., Solomon, H., Tasew, G., Tollera, G., Hailu, M., Juliano, J. J., Assefa, A., Parr, J. B., & Bailey, J. A. (2025). Rising prevalence of Plasmodium falciparum Artemisinin partial resistance mutations in Ethiopia. Communications Medicine. https://doi.org/10.1038/s43856-025-01008-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.